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Abstract Three new indole glycosides 22-deoxystrictosamide (1), 22-deoxystrictosamide Nb-oxide (2) and vincosamide
20-O-b-D-xylopyranoside-11-O-b-D-glucopyranoside (3), together with four known analogues were isolated from aqueous
fraction of Strychnos nitida. Their structures were elucidated on the basis of extensive analysis of spectroscopic data. All
the alkaloids were tested for their cytotoxic activity, but they did not show any exciting result.
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1 Introduction
Monoterpenoid indole alkaloids comprising of over 3000
natural alkaloids derived from condensation of tryptamine
and secologanin [1]. Many of them, such as yohimbine
[2], reserpine [3], and camptothecin [4] are well known
for their pharmacological significance. In our continual
searching for antitumor natural products, many cytotoxic
indoles and bisindoles with novel structures were isolated
[5–16]. Strychnos nitida G. Don (Loganiaceae) is a
medicinal plant indigenous to Yunnan province, China.
Previous investigations focused on the non-polar indoles
with different skeletons, which were responsible for their
medicinal properties, especially the remarkable strychnine
and brucine [17, 18]. The polar indole alkaloids in
aqueous fraction of medicinal plants were always
neglected, which inspired us to carry out phytochemical
investigation on aqueous fraction of S. nitida. As a result,
three new indole glycosides, 22-deoxystrictosamide (1),
22-deoxystrictosamide Nb-oxide (2) and vincosamide 20-
O-b-D-xylopyranoside-11-O-b-D-glucopyranoside (3),
together with four known analogues vincosamide (4) [19],
antirhine b-methochloride (5) [20], 3-epi-strictosidinic
acid (6) [21], vincoside (7) [22] were isolated. All alka-
loids (1–7) were evaluated for their cytotoxic activity, but
none of them showed exciting result against five human
cancer cell lines (T98G, U87, A549, GITC-3#, and GITC-
18#), though the various bioactivities of the chemical
constituents from Strychnos were reported previously
[23–27].
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2 Results and discussion
Compound 1 was deduced to have a molecular formula of
C26H32N2O7, as indicated by the observed ion peak at m/z
485.2283 [M ? H] ? (calcd. for 485.2282) in its HRE-
SIMS data, indicating 12 indices of hydrogen deficiency.
The 1H NMR spectrum exhibited four aromatic proton
signals assignable to an ortho-substituted benzene moiety
[dH 7.40 (1H, d, J = 8.0 Hz, H-9), 7.00 (1H, ddd, J =
8.0,7.1,1.0 Hz, H-10), 7.08 (1H, ddd, J = 8.0,7.1,1.0 Hz,
H-11), and 7.34 (1H, d, J = 8.0, H-12)], a typical indole
aromatic moiety (Table 1), which were in agreement with
the carbon signals at dC 118.6 (d, C-9), 119.9 (d, C-10),
122.1 (d, C-11), and 112.1 (d, C-12), supported by the
HSQC experiment. The 1H and 13C NMR data (Tables 1
and 2) of 1 exhibited high similarities with those of stric-
tosamide [19], except for a carbonyl group (dC 166.0)
replaced by a methylene group (dC 46.6; dH 3.45, 3.00) in
1. Comparing the 1H and 13C NMR spectral data of two
compounds, assumed the reduction of the carbonyl at C-22
in compound 1 by deshielded signal for C-5. This
assumption was further supported by the correlation of dH
4.47 (H-3) and 6.22 (H-17) with dC 46.6 (C-22) in the
HMBC spectrum. H-15 and H-20 of b-orientation and H-21
of b-orientation were derived from the iridiod secologanin.
In addition, The ROESY correlations of H-3 (dH 4.47, br s)
with one of H-14 (dH 1.91, td, J = 14.0, 5.1 Hz), H-15 (dH
2.47, m) with another H-14 (dH 2.32, ddd, J = 14.0, 5.1,
2.4 Hz) showed that H-3 and H-15 were located on the
opposite side. Detailed analysis of 2D NMR spectroscopic
data of 1 (Fig. 2) suggested that its other parts were the
same to those of strictosamide. Hence, the structure of 1
was elucidated to be 22-deoxystrictosamide (Fig. 1).
Compound 2 exhibited a molecular ion peak at m/z
500.2150 (calcd. for 500.2159) in its HREIMS spectrum,
indicating the molecular formula of C26H32N2O8, sixteen
mass units higher than that of 1. Its 1H NMR spectrum
revealed four downfield shifts signal at dH 4.68 (H-3), dH
3.77 (H-5) and dH 4.18 and 3.34 (H-22), while the
13C
NMR data exhibited noticeable downfield shifts involv-
ing dC 71.3 (C-3), dC 68.9 (C-5) and dC 60.1 (C-22) in 2
comparison to those of 1. These features are characteristic
of N (4)-oxides [28, 29], and which was further supported
by the HMBC correlations of dH 3.77 (H-5), 2.50 (H-15),
Table 1 The 1H NMR and 13C NMR data assignments for the aglycones of 1–3 (methanol-d4 d in ppm)
Position 1 2 3
dH (J in Hz) (400 M) dC (125 M) dH (J in Hz) (500 M) dC (125 M) dH (J in Hz) (400 M) dC (150 M)
2 132.9 130.4 133.3
3 4.47, br. s 55.1 4.68, br. s 71.3 4.94, d (11.2) 55.1
5a 3.27, overlap 51.7 3.77, m 68.9 5.06, dd (12.4, 4.0) 41.5
5b 2.99, td (12.4, 3.0)
6a 2.60, m 17.6 3.14-3.05, m 21.0 2.91, m 24.0
6b 3.08, m 3.32, overlap
7 107.4 106.6 109.0
8 128.8 127.8 118.7
9 7.40, d (8.0) 118.6 7.45, d (8.0) 119.1 7.00, d (8.6) 123.2
10 7.00, ddd (8.0, 7.1, 1.0) 119.9 7.05, ddd (8.0, 7.1, 1.0) 120.7 6.74, dd (8.6, 4.1) 104.4
11 7.08, ddd (8.0, 7.1, 1.0) 122.1 7.14, ddd (8.0, 7.1, 1.0) 123.3 153.3
12 7.34, d (8.0) 112.1 7.37, d (8.0) 112.6 7.00, d (4.1) 106.8
13 137.8 138.9 139.9
14a 1.91, td (14.0, 5.1) 29.9 2.23, ddd (14.1, 4.8, 1.6) 25.5 1.47, q (13.0) 32.5
14b 2.32, ddd (14.0, 5.1, 2.4) 2.69, overlap 2.48, dt (13.0, 3.6)
15 2.47, m 25.5 2.50, m 24.5 3.23, overlap 27.6
16 112.9 107.9 109.6
17 6.22, s 134.7 6.24, s 138.7 7.43, d (2.0) 149.0
18a 5.27, overlap 119.1 5.28, overlap 119.5 5.23, d (10.3) 120.5
18b 5.32, d (1.8) 5.31, d (1.8) 5.33, d (17.0)
19 5.82, dt (17.2, 10.2) 136.8 5.94, dt (17.2,10.2) 136.3 5.57, dt (17.2, 10.1) 133.9
20 2.69, m 46.6 2.68, overlap 46.4 2.73, dd (6.1, 2.2) 44.5
21 5.27, d (2.3) 97.2 5.28, d (1.8) 97.4 5.49, d (2.0) 97.2
22a 3.45, d (12.9) 46.6 4.18, d (13.2) 60.1 166.0
22b 3.01, overlap 3.34, s
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and 4.18 (H-22) with dC 71.3 (d, C-3). The ROESY cor-
relations indicated that the relative configuration of 2 was
the same as that of 1. Besides, other parts of 2 were
identical to those of 1 as supported by detailed analysis of
extensive 2D NMR spectral data of 2 (Fig. 2). Thus, the
structure of 2 was elucidated as 22-deoxystrictosamide Nb-
oxide (Fig. 1).
Compound 3, Its molecular formula was deduced as
C37H48N2O18 based on
13C NMR and HRESIMS data (m/z
831.2791 [M ? Na]?, calcd. for 831.2794). The 1H and
13C NMR spectra of 3 resembled those of vincosamide
11-O-b-D-glucopyranoside [22], but exhibited for more
one pentosyl moiety. Acid hydrolysis of 3 produced
D-xylose and D-glucose as sugar residues, which were
determined by GC analysis of their corresponding
trimethylsilylated L-cysteine adducts. The coupling con-
stants of the anomeric protons [dH 4.84 (d, J = 8.0 Hz,
H-10), 5.11 (d, J = 7.8 Hz, H-100) and 4.48 (d, J = 7.4 Hz,
H-1¢¢¢)] suggested b-pyranosyl configuration for both
D-xylose and D-glucose moieties. Since NMR signals of
three monosaccharides overlapped undesirablely, The
HSQC–TOCSY allowed all of the carbons belonging to
each sugar moiety. In particular, a first spin system con-
stituted by protons linked to six carbons at dC 97.7, 82.3,
77.9, 71.4, 78.2, and 62.6, the second represented by dC
102.0, 75.2, 78.1, 71.4, 78.6, and 62.6 and finally the third
originated by dC 106.2, 75.9, 77.6, 71.2, 67.3 (in good
accordance with the presence of xylose moiety) were evi-
dent (Table 2) [30]. The additional xylosyl moiety was
positioned at C-20 by the HMBC correlation between dH
4.48 (H-1¢¢¢) and dC 82.3 (C-20). Besides one more xylosyl,
the ROESY correlations were differ from 1 and 2, which
showed H-3 (dH 4.94, d, J = 11.2 Hz) with H-15 (3.22, m)
were cofacial, so H-3 was b-orientation. The planner
structure was identical to those of vincosamide 11-O-b-D-
glucopyranoside [22] as supported by intensive analysis of
its 2D NMR spectral data (Fig. 2). Then, the structure of 3
was elucidated to vincosamide 20-O-b-D-xylopyranoside-
11-O-b-D-glucopyranoside (Fig. 1).
3 Experimental Section
3.1 General Experimental Procedures
Optical rotations were obtained with a Jasco P-1020
Automatic Digital Polariscope. UV spectra were measured
with a Shi madzu UV2401PC spectrometer. IR spectra
were obtained on a Bruker FT-IR Tensor-27 infrared
spectrophotometer with KBr pellets. 1H, 13C, and 2D NMR
spectra were recorded on a Bruker DRX-400 NMR, Bruker
DRX-500 NMR and Bruker DRX-600 spectrometer with
Table 2 The NMR data assignments for the sugar moieties of 1–3 (methanol-d4 d in ppm)
Position 1 2 3
dH (J in Hz) dC dH (J in Hz) dC dH (J in Hz) dC
10 4.55, d (8.0) 99.4 4.51, d (8.0) 99.6 4.84, d (8.0) 97.7
20 3.01, overlap 74.4 2.97, dd (8.9, 8.0) 74.5 3.45, t (8.0) 82.3
30 3.28, overlap 78.0 3.22, overlap 78.0 3.61, t (8.7) 77.9
40 3.24, overlap 71.5 3.19, overlap 71.4 3.37, overlap 71.4
50 3.25, overlap 78.1 3.21, overlap 78.2 3.49, overlap 78.2
60a 3.65, dd (11.9, 5.5) 62.6 3.62, dd (11.9, 5.0) 62.6 3.70, m 62.6
60b 3.87, dd (11.9, 1.9) 3.84, dd (11.9, 1.9) 3.93, br. d (12.3)
100 5.11, d (7.8) 102.0
200 3.56, t (7.8) 75.2
300 3.34, overlap 78.1
400 3.43, overlap 71.4
500 3.50, overlap 78.6
600a 3.72, m 62.6
600b 3.93, br. d (12.3)
10 0 0 4.48, d (7.4) 106.2
20 0 0 3.22, overlap 75.9
30 0 0 3.30, t (8.9) 77.6
40 0 0 3.42, overlap 71.2
50 0 0a 3.79, dd (11.4, 5.3) 67.3
50 0 0b 3.14, t (11.2)
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TMS as internal standard. ESI-MS and HR-EI-MS analysis
were carried out on Waters Xevo TQS and Waters Auto-
Spec Premier P776 mass spectrometers, respectively.
Semi-preparative HPLC was performed on a Waters 600
HPLC with a COSMOSIL 5C18 MS-II (10ID 9 250 mm)
column. Silica gel (100–200 and 200–300 mesh, Qingdao
Marine Chemical Co. Ltd., P.R. China), Sephadex LH-20
(GE Healthcare Bio-Xciences AB), RP-18 gel (20–45 lm,
Fuji Silysia Chemical Ltd., Japan), and MCI gel
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Fig. 2 1H-1H COSY, ROESY and HMBC key correlations of alkaloids 1–3
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Japan) were used for column chromatography. Fractions
were monitored by TLC (GF 254, Qingdao Marine
Chemical Co., Ltd., Qingdao), and spots were visualized by
Dragendorff’s reagent.
3.2 Plant Material
Air-dried twigs of S. nitida were collected in November
2006 from Xishuangbanna, Yunnan province, P. R. China.
The plant was identified by Mr. Jing-Yun Cui, Xishuang-
banna Tropical Botanical Garden. Chinese Academy of
Sciences. A voucher specimen (No. Luo20060412) has
been deposited at the State Key Laboratory of Phyto-
chemistry and Plant Resources in West China, Kunming
Institute of Botany, Chinese Academy of Sciences.
3.3 Extraction and Isolation
The air-dried and powdered twigs of S. nitida (7.0 kg) were
extracted with MeOH under reflux conditions, and the
solvent was evaporated in vacuo. The residue was dis-
solved in 0.37% HCl (pH 2–3) and the solution was sub-
sequently basified using 10% ammonia to pH 9–10. The
basic solution was partitioned with EtOAc, affording a
two-phase mixture. The EtOAc fraction (40 g) and H2O
fraction (100 g). Then H2O fraction (100 g) was subjected
to a macroporous resin D101 and eluted with MeOH/H2O
system to give MeOH fraction (28 g). The MeOH fraction
(28 g) was separated by silica gel column chromatography
(CC), eluted with CHCl3/MeOH/H2O (10:1:0.1, 8:2:0.2,
7:3:0.5, 6:4:1, v/v/v) to give four subfractions (Fr. A-D)
and 7 (2.733 g). Fr. C (5.2 g) was separated on a Sephadex
LH-20 column eluting with MeOH, to obtain subfraction
C1 and C2. Subfraction C1 was then separated by RP-18
MPLC (MeOH/H2O, 8:92 to 60:40) and semipreparative
HPLC (MeCN/H2O, 20:80) to yield 1 (30.0 mg) and 4
(5.6 mg), Subfraction C2 was subjected to RP-18 CC
(MeOH/H2O, 10:90 to 50:50) and then purified by
semipreparative HPLC (MeCN/H2O, 25:75) to afford
alkaloids 5 (10.6 mg) and 6 (5.1 mg). Fr. D (7.2 g) was
chromatographed on macroporous resin MCI, Sephadex
LH-20 and Semi-preparative HPLC successively to afford
2 (36.1 mg) and 3 (2.3 mg).
3.3.1 22-Deoxystrictosamide (1)
Yellowish amorphous powder, [a]D
25-79.2 (c 0.15, MeOH);
UV (MeOH) kmax (log e) nm 225 (4.56), 209 (4.43), 281
(3.91); IR (KBr) m max 3423, 2923, 1450, 1317, 1238, 1138,
1075, 1013, 928, 743 cm-1; 1H, 13C-NMR spectroscopic
data see Table 1; ESIMS m/z 485 [M ? H]?; HRESIMS
m/z 485.2283 [M ? H]? (calcd for C26H32N2O7, 485.2282).
3.3.2 22-Deoxystrictosamide Nb-oxide (2)
Yellowish amorphous powder, [a]D
25-99.5 (c 0.10, MeOH);
UV (MeOH) kmax (log e) nm 221 (4.62), 274 (3.88); IR
(KBr) m max 3425, 2923, 1454, 1384, 1239, 1143, 1073,
1012, 935, 744 cm-1; 1H, 13C-NMR spectroscopic data see
Table 1; ESIMS m/z 501 [M ? H]?; HREIMS m/z
500.2150 [M]? (calcd for C26H32N2O18, 500.2159).
3.3.3 Vincosamide 20-O-b -D-xylopyranoside-11-O-b -D-
glucopyranoside (3)
Pale-yellow amorphous powder, [a]D
25-117.7 (c 0.10,
MeOH); UV (MeOH) kmax (log e) nm 226 (4.55), 199
(4.31); IR (KBr) m max 3442, 2924, 1633, 1432, 1383, 1248,
1169, 1073, 876, 598 cm-1; 1H, 13C-NMR spectroscopic
data see Table 1; ESIMS m/z 809 [M ? H]?; HRESIMS
m/z 831.2791 [M ? Na]? (calcd for C37H48N2O18,
831.2794).
3.4 Acid Hydrolysis of Compounds 1–3 and GC
Analysis
Compounds 1–3 (each 3 mg) were refluxed with 2 M HCl
(1, 4 dioxane/H2O 1:1, 2 mL) on water bath for 2 h. After
cooling, the reaction mixture was neutralized with 1 M
NaOH. The reaction mixture was extracted with CHCl3
(3 9 5 mL). The aqueous layer was evaporated to dryness.
The dried residue was dissolved in 1 mL anhydrous pyr-
idine and treated with L-cysteine methyl ester hydrochlo-
ride (1.5 mg) stirred at 60 C for 1 h.
Trimethylsilylimidazole (1.0 mL) was added to the reac-
tion mixtures, and they were kept at 60 C for 30 min. The
supernatants (4 lL) were analyzed by GC, respectively,
under the following conditions: H2 flame ionization
detector. Column: 30QC2/AC-5 quartz capillary column
(30 m 9 0.32 mm). Column temperature: 180–280 C
with the rate of 3 C/min, and the carrier gas was N2
(1 mL/min) injector temperature: 250 C; and split ratio:
1/50. Peaks of the hydrolysate were detected by compar-
ison with retention times of authentic samples of D-glucose
and D-xylose after treatment with trimethylchlorosilane
(TMCS) in pyridine. The absolute configurations of the
compounds 1–3 were determined by comparison of the
retention times of the corresponding derivatives with those
of standard D-glucose and D-xylose giving a single peak at
19.01 and 13.47 min, respectively.
3.5 Cytotoxic Activity Assay
The following human cancer cell lines were used: T98G,
U87, A549, GITC-3#, and GITC-18#. All cells were cul-
tured in RPMI-1640 or DMEM medium (Hyclone, Logan,
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UT), supplemented with 10% fetal bovine serum (Hyclone)
at 37 C in a humidified atmosphere with 5% CO2. Cell
viability was assessed by conducting colorimetric mea-
surements of the amount of insoluble formazan formed in
living cells based on the reduction of 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma,
St. Louis, MO) [31]. Briefly, 100 lL of adherent cells was
seeded into each well of a 96-well cell culture plate and
allowed to adhere for 12 h before drug addition, while
suspended cells were seeded just before drug addition, both
with an initial density of 1 9 105 cells/mL in 100 lL of
medium. Each cell line was exposed to the test compound
at various concentrations in triplicate for 48 h, with cis-
platin and paclitaxel (Sigma) as positive controls. After the
incubation, MTT (100 lg) was added to each well, and the
incubation continued for 4 h at 37 C. The cells were lysed
with 100 lL of 20% SDS-50% DMF after removal of 100
lL of medium. The optical density of the lysate was
measured at 595 nm in a 96-well Microtiter plate reader
(Bio-Rad 680).
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